{"id": 847858547731947521, "lang": "en", "text": "RT @NIAIDNews: Announced today: NIAID begins Phase 2 trial of its experimental #Zika #vaccine https://t.co/deBk99h7rf https://t.co/LIxXNpQZ\u2026", "urls": [{"url": "https://t.co/deBk99h7rf", "expanded_url": "https://www.niaid.nih.gov/news-events/phase-2-zika-vaccine-trial-begins-begins-us-central-and-south-america"}], "user": {"id": 44783853}, "id_str": "847858547731947521", "source": "<a href=\"https://sproutsocial.com\" rel=\"nofollow\">Sprout Social</a>", "deleted": false, "hashtags": [{"text": "Zika"}, {"text": "vaccine"}], "retrieved": "2018-09-27--06-45-05", "created_at": "Fri Mar 31 17:10:04 +0000 2017", "retweet_count": 27, "user_mentions": [{"id": 59769395, "name": "NIAID News", "screen_name": "NIAIDNews"}], "legacy_imported": true, "retweeted_status": {"id": 847840221936877568, "lang": "en", "text": "Announced today: NIAID begins Phase 2 trial of its experimental #Zika #vaccine https://t.co/deBk99h7rf https://t.co/LIxXNpQZbl", "urls": [{"url": "https://t.co/deBk99h7rf", "expanded_url": "https://www.niaid.nih.gov/news-events/phase-2-zika-vaccine-trial-begins-begins-us-central-and-south-america"}], "user": {"id": 59769395}, "media": [{"id": 847839699452534784, "url": "https://t.co/LIxXNpQZbl", "type": "photo", "sizes": {"large": {"h": 1536, "w": 2048, "resize": "fit"}, "small": {"h": 510, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 900, "w": 1200, "resize": "fit"}}, "media_url": "http://pbs.twimg.com/media/C8QhtvBXoAA8x1U.jpg", "display_url": "pic.twitter.com/LIxXNpQZbl", "expanded_url": "https://twitter.com/NIAIDNews/status/847840221936877568/photo/1", "media_url_https": "https://pbs.twimg.com/media/C8QhtvBXoAA8x1U.jpg"}], "id_str": "847840221936877568", "source": "<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>", "hashtags": [{"text": "Zika"}, {"text": "vaccine"}], "created_at": "Fri Mar 31 15:57:15 +0000 2017", "retweet_count": 27, "user_mentions": [], "favorite_count": 24}}